|
|
Country context and family research : trends from Malaysia
Item Type: Conference or Workshop Item
Editor:
Year: 00/01/2026
Abstract: Malaysia demographic transition: youth population shrinking, senior population growing and Malaysia entering an ageing society. Senior live longer, creating higher dependency ratios. For marriage and family trends there are declining marriage rates, delayed family formation. Divorce rates increasing, reshaping household stability. For household structure it shift from extended families to smaller nuclear households. Rising living costs discourage larger families. For fertility, Total Fertility Rate (TFR) is now below the replacement level (2.1)
|
|
|
|
|
|
Coconut water: a natural remedy unlocking new hope for male fertility
Item Type: Scientific Poster
Editor:
Year: 00/11/2025
Abstract: Male infertility are the inability of a men to impregnate a female after 1 year of unprotected intercourse. It high course of modern drugs and techniques to heal and involve ethical concerns. Then rely in alternative remedies derived from medicinal plants. Objectives of this study are to evaluate the potential of coconut water to support reproductive health of male for healing effects of coconut water and enhancing effects of coconut water. The conclusion oh healing effect of coconut water are mitigated the harmful effects of BPA on the male reproductive organs in rats. Enhancing effects of coconut water is coconut water alone enhanced reproductive organs in bucks.
|
|
|
|
|
|
Clinical evaluation of Buserelin, a GnRH analogue in the management of moderate to severe pelvic endometriosis
Item Type: Article
Editor:
Year: 00/12/1990
Abstract: A local study, a part of a multinasional and multicenter study on the efficacy and safety of Buserelin was carried out for the treatment of pelvic endometriosis using a standard protocol. 20 women diagnosed to have moderate to severe endometriosis by laparoscopy were recruited. The women were given 900 micrograms Buserelin acetate daily by intranasal spray for a fixed period of 6 months. Baseline hormonal and biochemical parameters were taken prior to treatment and the parameters were repeated during each follow-up at weekly and monthly intervals. In addition, changes in symptoms were monitored. A second look laparoscopy was performed at completion of therapy and patients were followed up for a further 6 months. There was 100 percent suppression of oestradiol levels during the 6 months treatment period. An improvement of implants according to AFS classification occured in all patients. One patient discontinued because of side effects. Restoration of cycles after completion of therapy occured within 7 weeks. There were 7 pregnancies (64%) in the first 6 months after treatment for those wanting pregnancies. During therapy, dysmenorrhoea, pelvic pain and dyspareunia improved considerably. Buserelin was proven to be effective in the management of pelvic endometriosis and is well tolerated and safe.
|
|
|
|